Anticoagulants and Bleeding Disorders Clinical Trial
Official title:
MAC Project, Monitoring of AntiCoagulant Therapies (MAC)
MAC Project is a prospective cohort, multicenter, observational, no-profit study aimed to prospectively collect reliable real-life clinical information in unselected VTE or NVAF patients treated with any DOAC, during a medium-long term follow-up period.
MAC Project is a prospective cohort, multicenter, observational, no-profit study aimed to prospectively collect reliable real-life clinical information in unselected VTE or NVAF patients treated with any DOAC, during a medium-long term follow-up period. Patients will be investigated in Italian hospital-based clinical centers, skilled in the management of adult patients with VTE or NVAF requiring anticoagulant treatment, and followed-up up to 5 years. The drugs will be prescribed according to current standards of care and regulations and not provided by any sponsor. The primary outcome is to collect and evaluate the safety and efficacy data of DOACs in a real-life setting, regardless of the underlying pathology, and the duration of treatment. The secondary outcome is to separately evaluate safety and efficacy of DOACs for treatment of cardiovascular diseases, specifically considering treatment duration, as follows: short-term (e.g., superficial venous thrombosis); medium-term (e.g., deep vein thrombosis, pulmonary embolism, etc.); long-term (e.g., atrial fibrillation, prevention of recurrent VTE or long-term treatment of recurrent VTE, peripheral arterial obstructive disease, etc.).Investigators will store event-driven clinical information into a REDCap based on-line EDC system about management and outcome of all efficacy and safety end-points; treatment compliance/adherence; VTE risk factors; thromboembolic and haemorrhagic risk-scores; comorbidities; concomitant treatments; patients' appreciation by a specific score (ACTS); clinical or adverse events; survival; possible causes of death. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04517461 -
Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery
|
||
| Terminated |
NCT03296033 -
Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin
|
Phase 4 | |
| Recruiting |
NCT05123326 -
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
|
||
| Completed |
NCT04074980 -
Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test
|
N/A | |
| Completed |
NCT04505475 -
Oral Surgery in Patients Taking Direct Oral Anticoagulants
|
||
| Not yet recruiting |
NCT05997914 -
Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
|
N/A | |
| Completed |
NCT03112525 -
DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic
|
||
| Not yet recruiting |
NCT06452342 -
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
|
Phase 4 | |
| Recruiting |
NCT03760874 -
Atrial Fibrillation Research Database
|
||
| Recruiting |
NCT04046029 -
Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
|
Phase 4 | |
| Completed |
NCT04444700 -
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic
|
Phase 3 | |
| Terminated |
NCT03566303 -
Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04128254 -
A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)
|
Phase 4 | |
| Recruiting |
NCT05946850 -
Caudal Analgesia & Anticoagulated Patient
|
||
| Completed |
NCT05946863 -
Caudal Block & Hip Fracture Surgery in Anticoagulated Patient
|
||
| Recruiting |
NCT05545475 -
Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
|
||
| Completed |
NCT06269302 -
Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
|
||
| Active, not recruiting |
NCT04676880 -
Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
|
N/A | |
| Completed |
NCT05224388 -
Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
|
||
| Completed |
NCT03871283 -
Anticoagulation and Antiplatelet Management During Perioperative Period
|